Brief: EMA Has Started Review Of Medicines Containing Finasteride & Dutasteride Following Concerns Regarding Suicidal Ideation

UCB SA

04/10/2024 11:42

Oct 4 (Reuters) - Merck & Co Inc  MRK.N :
    * EMA: HAS STARTED A REVIEW OF MEDICINES CONTAINING
FINASTERIDE
AND DUTASTERIDE FOLLOWING CONCERNS REGARDING SUICIDAL IDEATION
AND BEHAVIOURS
    * EMA: SUICIDAL IDEATION HAS ALSO RECENTLY BEEN ADDED AS A
POSSIBLE SIDE EFFECT OF UNKNOWN FREQUENCY IN PRODUCT INFORMATION
FOR PROPECIA AND PROSCAR
    * EMA: DIRECT HEALTHCARE PROFESSIONAL COMMUNICATION TO
INFORM
HEALTHCARE PROFESSIONALS OF POTENTIAL RISK OF MEDICATION ERRORS
IN KEPPRA & LEVETIRACETAM
    * EMA: MEDICATION ERRORS IN KEPPRA & LEVETIRACETAM DUE TO
CHANGE
IN VOLUME OF DOSING SYRINGE

Source text for Eikon:  ID: 
Further company coverage:  MRK.N 

 ((Reuters.Briefs@thomsonreuters.com;))